Key facts
- Marley Health’s last known valuation is $11.4M (Nov 2025).
- It has raised $9.3M; the latest was Early Stage VC ($9.3M) in Nov 2025.
- Notable investors include Parkwalk Advisors, University of Oxford, Oxford Science Enterprises.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Marley Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Marley Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Marley Health
Operator of a proactive pet care technology platform intended for enhancing veterinary communication and management. The company's platform leverages artificial intelligence and incorporates principles from human health technology to develop a comprehensive system for remote communication and proactive health monitoring, enabling pet owners and veterinary professionals to access consistent and preventative standards of care, ultimately addressing the existing challenges of brief visits and rising out-of-pocket expenses within the animal health sector.
- Sector
- Consumer Products and Services (B2C)
- HQ
- London, United Kingdom
- Founded
- 2025
- Employees
- 7
- Website
- marleyhealth.com/
- Ownership
- Privately Held (backing)
Marley Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Marley Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Marley Health in its N-PORT filings yet. We sweep new filings monthly.